Reply: Did animal offer relevant model for bevacizumab testing?

被引:1
作者
Bozec, A. [1 ]
Sudaka, A. [2 ]
Fischel, J. L. [1 ]
Brunstein, M. C. [2 ]
Grimaldi, M. C. [1 ]
Milano, G. [1 ]
机构
[1] Ctr Antoine Lacassagne, Oncopharmacol Unit, F-06189 Nice 2, France
[2] Ctr Antoine Lacassagne, Pathol Lab, F-06189 Nice 2, France
关键词
D O I
10.1038/sj.bjc.6604694
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1556 / 1556
页数:1
相关论文
共 2 条
[1]   Vertical VEGF targeting: A combination of ligand blockade with receptor tyrosine kinase inhibition [J].
Bozec, Alexandre ;
Gros, Francois-Xavier ;
Penault-Llorca, Frederique ;
Formento, Patricia ;
Cayre, Anne ;
Dental, Clelia ;
Etienne-Grimaldi, Marie-Christine ;
Fischel, Jean-Louis ;
Milano, Gerard .
EUROPEAN JOURNAL OF CANCER, 2008, 44 (13) :1922-1930
[2]  
Gerber HP, 2005, CANCER RES, V65, P671